Modulators of Sensitivity and Resistance to Inhibition of PI3K Identified in a Pharmacogenomic Screen of the NCI-60 Human Tumor Cell Line Collection

por Kwei, Kevin A., Baker, Joffre B., Pelham, Robert J.
Publicado em 2012

Transcriptional Repression of Catalase in Mouse Skin Tumor Progression

por Kwei, Kevin A, Finch, Joanne S, Thompson, Eric J, Bowden, G Tim
Publicado em 2004

Genomic instability in breast cancer: Pathogenesis and clinical implications

por Kwei, Kevin A., Kung, Yvonne, Salari, Keyan, Holcomb, Ilona N., Pollack, Jonathan R.
Publicado em 2010

Integrative Genomics Implicates EGFR as a Downstream Mediator in NKX2-1 Amplified Non-Small Cell Lung Cancer

por Clarke, Nicole, Biscocho, Jewison, Kwei, Kevin A., Davidson, Jean M., Sridhar, Sushmita, Gong, Xue, Pollack, Jonathan R.
Publicado no PLoS One (2015)

Integrin A6 Cleavage in Mouse Skin Tumors

por Demetriou, Manolis C., Kwei, Kevin A., Powell, Marianne B., Nagle, Raymond B., Bowden, G. Tim, Cress, Anne E.
Publicado em 2008

Recurrent rearrangements of the Myb/SANT-like DNA-binding domain containing 3 gene (MSANTD3) in salivary gland acinic cell carcinoma

por Barasch, Nicholas, Gong, Xue, Kwei, Kevin A., Varma, Sushama, Biscocho, Jewison, Qu, Kunbin, Xiao, Nan, Lipsick, Joseph S., Pelham, Robert J., West, Robert B., Pollack, Jonathan R.
Publicado no PLoS One (2017)

SMURF1 Amplification Promotes Invasiveness in Pancreatic Cancer

por Kwei, Kevin A., Shain, A. Hunter, Bair, Ryan, Montgomery, Kelli, Karikari, Collins A., van de Rijn, Matt, Hidalgo, Manuel, Maitra, Anirban, Bashyam, Murali D., Pollack, Jonathan R.
Publicado em 2011

Molecular Profiling of Breast Cancer Cell Lines Defines Relevant Tumor Models and Provides a Resource for Cancer Gene Discovery

por Kao, Jessica, Salari, Keyan, Bocanegra, Melanie, Choi, Yoon-La, Girard, Luc, Gandhi, Jeet, Kwei, Kevin A., Hernandez-Boussard, Tina, Wang, Pei, Gazdar, Adi F., Minna, John D., Pollack, Jonathan R.
Publicado em 2009

Genomic and functional analysis identifies CRKL as an oncogene amplified in lung cancer

por Kim, Young H., Kwei, Kevin A., Girard, Luc, Salari, Keyan, Kao, Jessica, Pacyna-Gengelbach, Manuela, Wang, Pei, Hernandez-Boussard, Tina, Gazdar, Adi F., Petersen, Iver, Minna, John D., Pollack, Jonathan R.
Publicado em 2009

CAMK1D amplification implicated in epithelial–mesenchymal transition in basal‐like breast cancer

por Bergamaschi, Anna, Kim, Young H., Kwei, Kevin A., La Choi, Yoon, Bocanegra, Melanie, Langerød, Anita, Han, Wonshik, Noh, Dong-Young, Huntsman, David G., Jeffrey, Stefanie S., Børresen-Dale, Anne-Lise, Pollack, Jonathan R.
Publicado em 2008

Genomic Profiling Identifies GATA6 as a Candidate Oncogene Amplified in Pancreatobiliary Cancer

por Kwei, Kevin A., Bashyam, Murali D., Kao, Jessica, Ratheesh, Raman, Reddy, Edumakanti C., Kim, Young H., Montgomery, Kelli, Giacomini, Craig P., Choi, Yoon-La, Chatterjee, Sreejata, Karikari, Collins A., Salari, Keyan, Wang, Pei, Hernandez-Boussard, Tina, Swarnalata, Gowrishankar, van de Rijn, Matt, Maitra, Anirban, Pollack, Jonathan R.
Publicado em 2008

Identification of recurrent SMO and BRAF mutations in ameloblastomas

por Sweeney, Robert T, McClary, Andrew C, Myers, Benjamin R, Biscocho, Jewison, Neahring, Lila, Kwei, Kevin A, Qu, Kunbin, Gong, Xue, Ng, Tony, Jones, Carol D, Varma, Sushama, Odegaard, Justin I, Sugiyama, Toshihiro, Koyota, Souichi, Rubin, Brian P, Troxell, Megan L, Pelham, Robert J, Zehnder, James L, Beachy, Philip A, Pollack, Jonathan R, West, Robert B
Publicado no Nat Genet (2014)